Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Return on Equity (2020 - 2025)

Goldenwell Biotech filings provide 6 years of Return on Equity readings, the most recent being 0.0% for Q3 2025.

  • On a quarterly basis, Return on Equity rose 11.0% to 0.0% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.0%, a 11.0% increase, with the full-year FY2024 number at 0.07%, down 6.0% from a year prior.
  • Return on Equity hit 0.0% in Q3 2025 for Goldenwell Biotech, down from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.03% in Q4 2024 to a low of 0.11% in Q3 2024.
  • Median Return on Equity over the past 5 years was 0.0% (2022), compared with a mean of 0.02%.
  • Biggest five-year swings in Return on Equity: decreased -8bps in 2023 and later increased 11bps in 2025.
  • Goldenwell Biotech's Return on Equity stood at 0.0% in 2021, then plummeted by -1102bps to 0.04% in 2022, then skyrocketed by 73bps to 0.01% in 2023, then soared by 310bps to 0.03% in 2024, then plummeted by -109bps to 0.0% in 2025.
  • The last three reported values for Return on Equity were 0.0% (Q3 2025), 0.0% (Q2 2025), and 0.01% (Q1 2025) per Business Quant data.